Immunohistochemistry results showed that TGFβ1 and SMAD family member 2 (Smad2) were expressed both in cancer cells and stromal cells, including lymphocytes, plasma cells, macrophages, and fibroblasts, in the tumor microenvironment. Here, SMAD2 is linked to neoplasm.